ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,415,822, issued on Sept. 16, was assigned to University of South Carolina (Columbia, S.C.).
"Small molecule inhibitors selective for polo-like kinase protein" was invented by Campbell McInnes (Irmo, S.C.) and Sandra Navonne Craig (Ellerbe, N.C.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are small molecule PLK inhibitors that can target the polo box domain (PBD). Inhibitors can have an atomic mass of about 1000 Da or less and a general structure ofFor instance, the inhibitors can include an alkyl benzamido benzoic acid core structure."
The patent was filed on Feb. 7, 2023, under Application No. 18/106,543.
*For further information, inclu...